-transparent.png){kind=logo}
Recent studies indicate that wild-type p53 can trigger cell apoptosis induced by many chemotherapeutic agents which induce DNA damage or cause disruptions of DNA metabolism, such as ADM, 5-FU, VP-16 and radiation. We introduced the wild-type p53 gene into a MDR cell line KBV200 in which the endogenous p53 was found to be rearranged. By G418 selection and Northern blot analysis, a G418-resistant clone named KBV200-p53 was obtained which continuously expressed the exogenous wild-type p53 mRNA. After treatment with Vincristine(VCR), the wild type p53-expression cells presented typical morphology characteristic of apoptosis analysed under electron and fluorescence microscopes. Flow cytometer analysis showed that the KBV200-p53 cells were more readily undergo apoptosis than their parental cells KBV200. After treatment with VCR 600 nmol.L-1 for 24 h, the apoptotic percentage of KBV200-p53 and KBV200 cells was about 42.4% and 8.4%, respectively. This result indicates that wild-type p53 stimulates VCR-induced apoptosis in KBV200 cells.
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
July 1997,
International journal of radiation oncology, biology, physics,
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
August 1997,
International journal of radiation oncology, biology, physics,
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
September 2009,
Cell cycle (Georgetown, Tex.),
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
February 1997,
The Biochemical journal,
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
April 2002,
FEBS letters,
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
June 2008,
Neoplasia (New York, N.Y.),
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
December 1998,
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
September 2000,
Biochemical and biophysical research communications,
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
June 1998,
Zhonghua bing li xue za zhi = Chinese journal of pathology,
Z H Li, and
Y J Zhu, and
L S Chao, and
X T Li
April 2001,
Neuro-oncology,
